The Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy

 

 Buy Article Permissions and Reprints

ABSTRACT

Chronic inflammatory demyelinating polyradiculoneuropathy is an inflammatory disorder of nerve that usually presents with slowly progressive weakness and sensory loss and areflexia. It is among the most treatable of the peripheral nerve disorders, and several modalities have been shown to be effective in prospective, randomized controlled trials. Although most patients show a gratifying early response to treatment, in many cases the patients relapse. The cumulative effects of the neuropathic impairments, along with side effects from long-term immunosuppressive treatment, combine to produce significant long-term morbidity and loss of function. This review will cover the epidemiology, clinical features, laboratory findings, and pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy; the current status of the treatment of this disorder will be reviewed, highlighting those therapies shown to be effective in randomized controlled trials.

REFERENCES

• 1 Lunn M PT, Manji H, Choudhary P P. et al . Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England.  J Neurol Neurosurg Psychiatry . 1999;  66 269-271
  PubMedGoogle Scholar
• 2 McLeod J G, Pollard J D, Macaskill P. et al . Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia.  Ann Neurol . 1999;  46 910-913
  CrossrefPubMedGoogle Scholar
• 3 Hughes R AC. Chronic inflammatory demyelinating polyradiculoneuropathy.  Ann Neurol . 2001;  50 281-282
  CrossrefPubMedGoogle Scholar
• 4 Dyck P J, Oviatt K F, Lambert E H. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis.  Ann Neurol . 1981;  10 222-226
  CrossrefPubMedGoogle Scholar
• 5 Barohn R J. Approach to peripheral neuropathy and neuronopathy.  Sem Neurol . 1998;  18 7-18
  PubMedGoogle Scholar
• 6 McCombe P A, Pollard J D, McLeod J G. Chronic inflammatory demyelinating polyradiculoneuropathy: a clinical and electrophysiological study of 92 cases.  Brain . 1987;  110 1617-1630
  CrossrefPubMedGoogle Scholar
• 7 Barohn R J, Kissel J T, Warmolts J R, Mendell J R. Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria.  Arch Neurol . 1989;  46 878-884
  CrossrefPubMedGoogle Scholar
• 8 Barbieri F, De Michele G, Santoro L, Santangelo R, Ragno M. Chronic inflammatory demyelinating polyradiculoneuropathy: a clinical, electrophysiological and biopsy study.  Clin Neurol Neurosurg . 1991;  93 99-106
  CrossrefPubMedGoogle Scholar
• 9 Bromberg M B, Feldman E L, Albers J W. Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy.  Neurology . 1992;  42 1157-1163
  PubMedGoogle Scholar
• 10 Nevo Y, Pestronk A, Kornberg A J. et al . Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up.  Neurology . 1996;  47 98-102
  PubMedGoogle Scholar
• 11 Maisonobe T, Chassande B, Verin M, Jouni M, Leger J M, Bouche P. Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients.  J Neurol Neurosurg Psych . 1996;  61 36-42
  PubMedGoogle Scholar
• 12 Gorson K C, Allam G, Ropper A H. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy.  Neurology . 1997;  48 321-328
  CrossrefPubMedGoogle Scholar
• 13 Bouchard C, Lacroix C, Plante V. et al . Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy.  Neurology . 1999;  52 498-503
  PubMedGoogle Scholar
• 14 Sghirlanzoni A, Solari A, Ciano C, Mariotti C, Fallica E, Pareyson D. Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients.  Neurol Sci . 2000;  21 31-37
  CrossrefPubMedGoogle Scholar
• 15 Bosboom W M, van den Berg H L, Fransssen H. et al . Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy.  Brain . 2001;  124 2427-2438
  CrossrefPubMedGoogle Scholar
• 16 Simmons Z, Wald J J, Albers J W. Chronic inflammatory demyelinating polyradiculoneuropathy in children I: presentation, electrodiagnostic studies, and initial clinical course, with comparison to adults.  Muscle Nerve . 1997;  20 1008-1015
  PubMedGoogle Scholar
• 17 Hattori N, Ichimura M, Aoki S. et al . Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood.  J Neurol Sci . 1998;  154 66-71
  CrossrefPubMedGoogle Scholar
• 18 Ryan M M, Grattan-Smith P J, Procopis P G, Morgan G, Ouvrier R A. Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and long-term outcome.  Neuromuscul Disord . 2000;  10 398-406
  PubMedGoogle Scholar
• 19 Nevo Y, Topaloglu H. 88th ENMC international workshop: childhood chronic inflammatory demyelinating polyneuropathy (including revised diagnostic criteria).  Neuromuscul Disord . 2002;  12 195-200
  PubMedGoogle Scholar
• 20 Connolly A M. Chronic inflammatory demyelinating polyneuropathy in childhood.  Ped Neurology . 2001;  24 177-182
  PubMedGoogle Scholar
• 21 Mori K, Hattori N, Sugiura M. et al . Chronic inflammatory demyelinating polyneuropathy presenting with features of GBS.  Neurology . 2002;  58 979-982
  PubMedGoogle Scholar
• 22 Waddy H M, Misra V P, King R H, Thomas P K, Middleton L, Ormerod I E. Focal cranial nerve involvement in chronic inflammatory demyelinating polyneuropathy: clinical and MRI evidence of peripheral and central lesions.  J Neurol . 1989;  236 400-405
  PubMedGoogle Scholar
• 23 McCann E L, Smith T W, Chad D A, Sargent J. Severe cranial nerve involvement in longstanding demyelinating polyneuropathy: a clinicopathologic correlation.  Acta Neuropath . 1996;  91 309-312
  PubMedGoogle Scholar
• 24 Midroni G, Dyck P J. Chronic inflammatory demyelinating polyradiculoneuropathy: unusual clinical features and therapeutic responses.  Neurology . 1996;  46 1206-1212
  PubMedGoogle Scholar
• 25 Dalakas M C. Advances in chronic inflammatory demyelinating polyneuropathy: disease variants and inflammatory response mediators and modifiers.  Curr Opin Neurol . 1999;  12 403-409
  CrossrefPubMedGoogle Scholar
• 26 Saperstein D S, Katz J S, Amato A A, Barohn R J. Clinical spectrum of chronic acquired demyelinating polyneuropathies.  Muscle Nerve . 2001;  24 311-324
  CrossrefPubMedGoogle Scholar
• 27 Kuwabara S, Ogawara K, Misawa S, Mori M, Hattori T. Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy.  J Neurol Neurosurg Psychiatry . 2002;  72 37-42
  CrossrefPubMedGoogle Scholar
• 28 Hausmanowa-Petrusewicz I, Rowinska-Marcinska K, Kopec A. Chronic acquired demyelinating motor neuropathy.  Acta Neurol Scand . 1991;  84 40-45
  PubMedGoogle Scholar
• 29 Donaghy M, Mills K R, Boniface S J. et al . Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin.  J Neurol Neurosurg Psych . 1994;  57 778-783
  PubMedGoogle Scholar
• 30 Sabatelli M, Madia F, Mignogna T, Lippi G, Quaranta L, Tonali P. Pure motor chronic inflammatory demyelinating polyneuropathy.  J Neurol . 2001;  248 772-777
  PubMedGoogle Scholar
• 31 Oh S J, Joy J L, Kuruoglu R. "Chronic sensory demyelinating neuropathy": chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy.  J Neurol Neurosurg Psychiatry . 1992;  55 677-680
  CrossrefPubMedGoogle Scholar
• 32 van Dijk W G, Notermans N C, Franssen H, Wokke J H. Development of weakness in patients with chronic inflammatory demyelinating polyneuropathy and only sensory symptoms at presentation: a long-term follow-up study.  J Neurol . 1999;  246 1134-1139
  PubMedGoogle Scholar
• 33 Ohkoshi N, Harada K, Magata H, Yato M, Shoji S. Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy: clinical features and pathological study of the sural nerves.  Eur Neurol . 2001;  45 241-248
  CrossrefPubMedGoogle Scholar
• 34 Lewis R A, Sumner A J, Brown M J, Asbury A K. Multifocal demyelinating neuropathy with persistent conduction block.  Neurology . 1982;  32 958-964
  CrossrefPubMedGoogle Scholar
• 35 Thomas P K, Claus D, Jaspert A. et al . Focal upper limb demyelinating neuropathy.  Brain . 1996;  119 765-774
  PubMedGoogle Scholar
• 36 Oh S J, Claussen G C, Odabasi Z, Palmer C P. Multifocal demyelinating motor neuropathy: pathologic evidence of inflammatory demyelinating polyradiculoneuropathy.  Neurology . 1995;  45 1828-1832
  PubMedGoogle Scholar
• 37 Van den Berg-Vos M R, Van den Berg H L, Franssen H. et al . Multifocal inflammatory demyelinating neuropathy: a distinct clinical entity?.  Neurology . 2000;  54 26-32
  CrossrefPubMedGoogle Scholar
• 38 Frohman E M, Tusa R, Mark A S, Cornblath D R. Vestibular dysfunction in chronic inflammatory demyelinating polyneuropathy.  Ann Neurol . 1996;  39 529-535
  CrossrefPubMedGoogle Scholar
• 39 Donaghy M, Earl C J. Ocular palsy preceding chronic relapsing polyneuropathy by several weeks.  Ann Neurol . 1985;  17 49-50
  CrossrefPubMedGoogle Scholar
• 40 Gupta V K. Ocular palsy and CIPD [comment; letter].  Neurology . 1996;  47 306
  PubMedGoogle Scholar
• 41 Dalakas M C, Teravainen H, Engel W K. Tremor as a feature of chronic relapsing and dysgammaglobulinemic polyneuropathies: incidence and management.  Arch Neurol . 1984;  41 711-714
  PubMedGoogle Scholar
• 42 Sakakibara R, Hattori T, Kuwabara S, Yamanishi T, Yasuda K. Micturitional disturbance in patients with chronic inflammatory demyelinating polyneuropathy.  Neurology . 1998;  50 1179-1182
  CrossrefPubMedGoogle Scholar
• 43 Mendell J R, Kolkin S, Kissel J T, Weiss K L, Chakeres D W, Rammohan K W. Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy.  Neurology . 1987;  37 1291-1294
  CrossrefPubMedGoogle Scholar
• 44 Thomas P K, Walker R W, Rudge P. et al . Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination.  Brain . 1987;  110 53-76
  PubMedGoogle Scholar
• 45 Pakalnis A, Drake Jr E M, Barohn R J, Chakeres D W, Mendell J R. Evoked potentials in chronic inflammatory demyelinating polyneuropathy.  Arch Neurol . 1988;  45 1014-1016
  PubMedGoogle Scholar
• 46 Uncini A, Gallucci M, Lugaresi A, Porrini A M, Onofrj M, Gambi D. CNS involvement in chronic inflammatory demyelinating polyneuropathy: an electrophysiological and MRI study.  Electromyogr Clin Neurophysiol . 1991;  31 365-371
  PubMedGoogle Scholar
• 47 Feasby T E, Hahn A F, Koopman W J, Lee D H. Central lesions in chronic inflammatory demyelinating polyneuropathy: an MRI study.  Neurology . 1990;  40 476-478
  PubMedGoogle Scholar
• 48 Naganuma M, Shima K, Matsumoto A, Tashiro K. Chronic multifocal demyelinating neuropathy associated with central nervous system demyelination.  Muscle Nerve . 1991;  14 953-959
  PubMedGoogle Scholar
• 49 Crino P B, Grossman R I, Rostami A. Magnetic resonance imaging of the cauda equina in chronic inflammatory demyelinating polyneuropathy.  Ann Neurol . 1993;  33 311-313
  CrossrefPubMedGoogle Scholar
• 50 De Silva N R, Willison H J, Doyle D, Weir A I, Hadley D M, Thomas A M. Nerve root hypertrophy in chronic inflammatory demyelinating polyneuropathy.  Muscle Nerve . 1994;  17 168-170
  PubMedGoogle Scholar
• 51 Ginsberg L, Platts A D, Thomas P K. Chronic inflammatory demyelinating polyneuropathy mimicking a lumbar spinal stenosis syndrome.  J Neurol Neurosurg Psychiatry . 1995;  59 189-191
  PubMedGoogle Scholar
• 52 Goldstein J M, Parks B J, Mayer P L, Kim J H, Sze G, Miller R G. Nerve root hypertrophy as the cause of lumbar stenosis in chronic inflammatory demyelinating polyradiculoneuropathy.  Muscle Nerve . 1996;  19 892-896
  PubMedGoogle Scholar
• 53 Mizuno K, Nagamatsu M, Hattori N. et al . Chronic inflammatory demyelinating polyradiculoneuropathy with diffuse and massive peripheral nerve hypertrophy: distinctive clinical and magnetic resonance imaging features.  Muscle Nerve . 1998;  21 805-808
  PubMedGoogle Scholar
• 54 Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy.  Neurology . 1991;  41 617-618
  PubMedGoogle Scholar
• 55 Uncini A, Di Muzio A, Sabatelli M, Magi S, Tonali P, Gambi D. Sensitivity and specificity of diagnostic criteria for conduction block in chronic inflammatory demyelinating polyneuropathy.  Electroencephalogr Clin Neurophysiol . 1993;  89 161-169
  PubMedGoogle Scholar
• 56 Haq R U, Fries T J, Pendlebury W W, Kenny M J, Badger G J, Tandan R. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria.  Arch Neurol . 2000;  57 1745-1750
  CrossrefPubMedGoogle Scholar
• 57 Wilson J R, Park Y, Fisher M A. Electrodiagnostic criteria in CIDP: comparison with diabetic neuropathy.  Electromyogr Clin Neurophysiol . 2000;  40 181-185
  PubMedGoogle Scholar
• 58 Nicolas G, Maisonobe T, Le Forestier N, Leger J M, Bouche P. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy.  Muscle Nerve . 2002;  25 26-30
  CrossrefPubMedGoogle Scholar
• 59 Rotta F T, Sussman A T, Bradley W G, Ayyar D R, Sharma K R, Shebert R T. The spectrum of chronic inflammatory demyelinating polyneuropathy.  J Neurol Sci . 2000;  173 129-139
  CrossrefPubMedGoogle Scholar
• 60 Matsumuro K, Izumo S, Umehara F, Osame M. Chronic inflammatory demyelinating polyneuropathy: histological and immunopathological studies on biopsied sural nerves.  J Neurol Sci . 1994;  127 170-178
  CrossrefPubMedGoogle Scholar
• 61 Schmidt B, Toyka K V, Kiefer R, Full J, Hartung H P, Pollard J. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy.  Muscle Nerve . 1996;  19 474-487
  CrossrefPubMedGoogle Scholar
• 62 Molenaar D S, Vermeulen M, de Haan R. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy.  J Neurol Neurosurg Psych . 1998;  64 84-89
  PubMedGoogle Scholar
• 63 Bosboom W MJ, van den Berg H L, De Boer L. et al . The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy.  Neurology . 1999;  53 837-845
  CrossrefPubMedGoogle Scholar
• 64 Uncini A, De Angelis V M, Di Muzio A. et al . Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy.  Clin Neurophysiol . 1999;  110 705-711
  CrossrefPubMedGoogle Scholar
• 65 Gabriel C M, Howard R, Kinsella N. et al . Prospective study of the usefulness of sural nerve biopsy.  J Neurol Neurosurg Psychiatry . 2000;  69 442-446
  CrossrefPubMedGoogle Scholar
• 66 Hartung H-P, Toyka K V, Griffin J W. Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. In: Antel J, Birnbaum G, Hartung HP, eds. Neuroimmunology Cambridge: Blackwell Science 1998: 294-315
  Google Scholar
• 67 Yan W X, Taylor J, Andrias-Kauba S, Pollard J D. Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients.  Ann Neurol . 2000;  47 765-775
  CrossrefPubMedGoogle Scholar
• 68 Yan W X, Archelos J J, Hartung H P, Pollard J D. P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy.  Ann Neurol . 2001;  50 286-292
  CrossrefPubMedGoogle Scholar
• 69 Gabriel C M, Gregson N A, Hughes R AC. Anti-PMP22 antibodies in patients with inflammatory neuropathy.  J Neuroimmunol . 2000;  104 139-146
  CrossrefPubMedGoogle Scholar
• 70 Connolly A M, Pestronk A. Anti-tubulin autoantibodies in acquired demyelinating polyneuropathies.  J Infect Dis . 1997;  176 S157-S159
  PubMedGoogle Scholar
• 71 Melendez-Vasquez C, Redford J, Choudhary P P. et al . Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy.  J Neuroimmunol . 1997;  73 124-134
  CrossrefPubMedGoogle Scholar
• 72 Ritz M F, Lechner-Scott J, Scott R J. et al . Characterization of autoantibodies to peripheral myelin protein 22 in patients with hereditary and acquired neuropathies.  J Neuroimmunol . 2000;  104 155-163
  CrossrefPubMedGoogle Scholar
• 73 van Schaik N I, Vermeulen M, van Doorn A P, Brand A. Anti-beta-tubulin antibodies have no diagnostic value in patients with chronic inflammatory demyelinating polyneuropathy.  J Neurol . 1995;  242 599-603
  PubMedGoogle Scholar
• 74 Tagawa Y, Yuki N, Hirata K. The 301 to 314 amino acid residue of β-tubulin is not a target epitope for serum IgM antibodies in chronic inflammatory demyelinating polyneuropathy.  J Neurol Sci . 1999;  163 44-46
  CrossrefPubMedGoogle Scholar
• 75 Yuki N, Tagawa Y, Handa S. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.  J Neuroimmunol . 1996;  70 1-6
  CrossrefPubMedGoogle Scholar
• 76 Ilyas A A, Mithen F A, Dalakas M C, Chen Z W, Cook S D. Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.  J Neurol Sci . 1992;  107 111-121
  CrossrefPubMedGoogle Scholar
• 77 Simone I L, Annunziata P, Maimone D, Liguori M, Leante R, Livrea P. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.  J Neurol Sci . 1993;  114 49-55
  CrossrefPubMedGoogle Scholar
• 78 Oka N, Akiguchi I, Kawasaki T, Mizutani K, Satoi H, Kimura J. Tumor necrosis factor-α in peripheral nerve lesions.  Acta Neuropathol . 1998;  95 57-62
  CrossrefPubMedGoogle Scholar
• 79 Mathey E K, Pollard J D, Armati P J. TNF-α, INF-γ and IL-2 mRNA expression in CIDP sural nerve biopsies.  J Neurol Sci . 1999;  163 47-52
  CrossrefPubMedGoogle Scholar
• 80 Sharief M K, Ingram D A, Swash M, Thompson E J. IV immunoglobulin reduces circulating proinflammatory cytokines in Guillain-Barré syndrome.  Neurology . 1999;  52 1833-1838
  PubMedGoogle Scholar
• 81 Dyck P J, O'Brien P C, Oviatt K F. et al . Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment.  Ann Neurol . 1982;  11 136-141
  CrossrefPubMedGoogle Scholar
• 82 Mehndiratta M M, Hughes R A. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.  Cochrane Database Syst Rev . 2002;  1 CD002062
  PubMedGoogle Scholar
• 83 Dyck P J, Daube J, O'Brien P. et al . Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy.  N Engl J Med . 19896;  314 461-465
  PubMedGoogle Scholar
• 84 Hahn A F, Bolton C F, Pillay N. et al . Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy: a double-blind, sham-controlled, cross-over study.  Brain . 1996;  119 1055-1066
  CrossrefPubMedGoogle Scholar
• 85 Dyck P J, Litchy W J, Kratz K M. et al . A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.  Ann Neurol . 1994;  36 838-845
  CrossrefPubMedGoogle Scholar
• 86 Vermeulen M, van Doorn A P, Brand A, Strengers P F, Jennekens F G, Busch H F. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study.  J Neurol Neurosurg Psychiatry . 1993;  56 36-39
  CrossrefPubMedGoogle Scholar
• 87 van Doorn A P, Brand A, Strengers P F, Meulstee J, Vermeulen M. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study.  Neurology . 1990;  40 209-212
  PubMedGoogle Scholar
• 88 Hahn A F, Bolton C F, Zochodne D, Feasby T E. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, cross-over study.  Brain . 1996;  119 1067-1077
  CrossrefPubMedGoogle Scholar
• 89 Mendell J R, Barohn R J, Freimer M L. et al . Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy.  Neurology . 2001;  56 445-449
  CrossrefPubMedGoogle Scholar
• 90 Hughes R, Bensa S, Willison H. et al . Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.  Ann Neurol . 2001;  50 195-201
  CrossrefPubMedGoogle Scholar
• 91 Dyck P J, O'Brien P, Swanson C, Low P, Daube J. Combined azathioprine and prednisone in chronic inflammatory-demyelinating polyneuropathy.  Neurology . 1985;  35 1173-1176
  CrossrefPubMedGoogle Scholar
• 92 Kolkin S, Nahman Jr S N, Mendell J R. Chronic nephrotoxicity complicating cyclosporine treatment of chronic inflammatory demyelinating polyradiculoneuropathy.  Neurology . 1987;  37 147-149
  PubMedGoogle Scholar
• 93 Hodgkinson S J, Pollard J D, McLeod J G. Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy.  J Neurol Neurosurg Psychiatry . 1990;  53 327-330
  CrossrefPubMedGoogle Scholar
• 94 Barnett M H, Pollard J D, Davies L, McLeod J G. Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy.  Muscle Nerve . 1998;  21 454-460
  CrossrefPubMedGoogle Scholar
• 95 Good J L, Chehrenama M, Mayer R F, Koski C L. Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy.  Neurology . 1998;  51 1735-1738
  CrossrefPubMedGoogle Scholar
• 96 Brannagan T H, Pradhan A, Heiman-Patterson T. et al . High-dose cyclophosphamide without stem-cell rescue for refractory CIDP.  Neurology . 2002;  58 1856-1858
  CrossrefPubMedGoogle Scholar
• 97 Gorson K C, Allam G, Simovic D, Ropper A H. Improvement following interferon-alpha 2A in chronic inflammatory demyelinating polyneuropathy.  Neurology . 1997;  48 777-780
  CrossrefPubMedGoogle Scholar
• 98 Gorson K C, Ropper A H, Clark B D, Dew III B R, Simovic D, Allam G. Treatment of chronic inflammatory demyelinating polyneuropathy with interferon-alpha 2a.  Neurology . 1998;  50 84-87
  CrossrefPubMedGoogle Scholar
• 99 Sabatelli M, Mignogna T, Lippi G. et al . Interferon-alpha may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy.  J Neurol Neurosurg Psychiatry . 1995;  58 638-639
  CrossrefPubMedGoogle Scholar
• 100 Choudhary P P, Thompson N, Hughes R A. Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy.  J Neurol . 1995;  242 252-253
  CrossrefPubMedGoogle Scholar
• 101 Martina I SJ, van Doorn A P, Schmitz P IM, Meulstee J, van der Meche G A F. Chronic motor neuropathies: response to interferon-b1a after failure of conventional therapies.  J Neurol Neurosurg Psychiatry . 1999;  66 197-201
  PubMedGoogle Scholar
• 102 Rosenberg N L, Lacy J R, Kennaugh R C, Holers V M, Neville H E, Kotzin B L. Treatment of refractory chronic demyelinating polyneuropathy with lymphoid irradiation.  Muscle Nerve . 1985;  8 223-232
  PubMedGoogle Scholar
• 103 Palace J, Newsom-Davis J, Lecky B. A randomized, double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.  Neurology . 1998;  50 1778-1783
  CrossrefPubMedGoogle Scholar
• 104 Nagamatsu M, Terao S, Misu K. et al . Axonal and perikaryal involvement in chronic inflammatory demyelinating polyneuropathy.  J Neurol Neurosurg Psychiatry . 1999;  66 727-734
  PubMedGoogle Scholar
• 105 Dawson-Hughes B, Harris S S, Krall E A, Dallas G E. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.  N Engl J Med . 1997;  337 670-676
  CrossrefPubMedGoogle Scholar
• 106 Prince R L. Diet and the prevention of osteoporotic fractures.  N Engl J Med . 1997;  337 701-702
  PubMedGoogle Scholar
• 107 Adachi J D, Bensen W G, Brown J. et al . Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.  N Engl J Med . 1997;  337 382-387
  CrossrefPubMedGoogle Scholar
• 108 Libby P, Ganz P. Preventing glucocorticoid-induced osteoporosis.  N Engl J Med . 1997;  337 420-421
  PubMedGoogle Scholar